Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Balloons Catheters - Medical Devices Pipeline Assessment, 2019
Summary
The Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019“ provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Reasons to buy
The report enables you to -
Summary
The Medical Devices sector report, “Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Medical Devices Pipeline Assessment, 2019“ provides an overview of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Introduction
2 Products under Development
3 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters - Pipeline Products under Development by Companies
4 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters Companies and Product Overview
5 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons Catheters- Recent Developments
6 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3DT Holdings LLC
- Aachen Resonance GmbH
- Acrostak (Schweiz) AG
- AlviMedica Medical Technologies Inc
- Andramed GmbH
- Atrium Medical Corp
- B. Braun Interventional Systems Inc
- Bolton Medical Inc
- Boston Scientific Corp
- BrosMed Medical Co., Ltd
- Caliber Therapeutics Inc
- Cardionovum GmbH
- Concept Medical Inc
- Cordis Corp
- CorNova Inc
- Innovia LLC
- iVascular SLU
- Kaneka Corp
- Lifetech Scientific (Shenzhen) Co Ltd
- Lithotech Medical Ltd
- Medix Innovators Inc.
- Medtronic plc
- Meril Life Sciences Pvt Ltd
- MicroPort Scientific Corp
- Natec Medical Ltd
- OrbusNeich
- Orchestra BioMed Inc
- QT Vascular Ltd
- QualiMed Innovative Medizinprodukte GmbH
- Sahajanand Medical Technologies Pvt Ltd
- SIS Medical AG
- Spectranetics Corp
- Vascular Nanotransfer Technologies
- VasoTech Inc.
